Temple Faculty Physicians is experiencing technical issues with phone lines. If you are experiencing an emergency, please visit your nearest emergency room. If you would like to schedule an appointment with your provider or have general questions or requests, please contact us by using myTempleHealth.

myTempleHealth
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial (NAIL-IT)

view all Clinical Trials

Overview

Evaluation of safety and thrombolytic effect of ascending doses of TS23 in subjects with intermediate-risk (sub-massive) acute pulmonary embolism (PE).

Clinical Trial Information

Protocol

TIRB# 30780

Phase

2

Condition(s)

Pulmonary Embolism, Pulmonary Vascular Disease

Investigator

Parth Rali, MD

Coordinator

Kim Selwood

Visit clinicaltrials.gov for full description.

Contact

For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.

Full Title

Evaluation of the Safety and Thrombolytic Effects of Ascending Doses of TS23 in Subjects With Intermediate-Risk (Sub-Massive) Acute Pulmonary Embolism

Related Clinical Trials

The RESCUE II Study. The Bashir™ Endovascular Catheter (BEC)

TIRB# 30769
  • Conditions: Pulmonary Embolism, Pulmonary Vascular Disease
  • Investigator: Parth Rali, MD
  • Coordinator: Kim Selwood
View Details